Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
SK Channels as a New AAD Target
Author(s): Arnela Saljic , Jordi Heijman , Dobromir Dobrev Added: 1 year ago

Electrophysiology & Arrhythmia
Author(s): Alexander Fanaroff Added: 1 year ago
ACC.24 — Dr Alexander Fanaroff (Penn Medicine, US) joins us onsite at ACC.24 to discuss the findings from the BE ACTIVE study, which investigated behavioural economic approaches to increasing physical activity (PA) in patients with an elevated risk of cardiovascular disease (NCT03911141).This randomized, controlled trial enrolled 1062 patients with a 10-year atherosclerotic cardiovascular risk… View more

Prevention & Chronic Conditions
Job title: Lead Cardiologist
Dr John Davies trained at Guy's Hospital and qualified with a distinctions in clinical pharmacology and medicine in 1997. He started his training in Cardiology in 2000 including specialist training in interventional coronary cardiology at St Bartholomew's, The London Chest and The Essex Cardiothoracic Centre.He completed his specialist training in 2008 and was appointed as a consultant… View more
Teresa Taft Levitch is a strategic healthcare communicator, writer, and patient advocate whose work focuses on cancer rehabilitation, survivorship, and cardiovascular health. She has developed patient-centered content and campaigns for organisations including the CDC Foundation, AstraZeneca, Memorial Sloan Kettering Cancer Center, the American Heart Association, and the Cancer Survivorship &… View more
Apabetalone: Evidence and Outcomes Related to Cardiovascular Health
Author(s): Yimeng Zhang , Nimai Desai , Derek Connolly Added: 10 months ago

Prevention & Chronic Conditions

CV Disease in Special Populations
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 9 months ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery
Sylwia Sławek-Szmyt
Job title: Interventional Cardiologist
Sylwia Sławek-Szmyt is an Assistant Professor and Consultant Cardiologist at the Department of Cardiology, Poznan University of Medical Sciences, Poland, with a focus on interventional cardiology and pulmonary embolism care. She leads the outpatient clinic for patients after pulmonary embolism and performs a wide range of catheter-based coronary, structural, and pulmonary vascular interventions… View more
Factor XI Inhibition and AF
Author(s): Bianca Rocca , Hugo ten Cate Added: 9 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Tomohiro Sakamoto
Job title: Interventional Cardiologist
Dr Tomohiro Sakamoto is an interventional cardiologist at the Cardiovascular Center of Saiseikai Kumamoto Hospital, where he specialises in structural heart disease and percutaneous coronary interventions.He is actively involved in advanced valvular and structural heart therapies - including transcatheter aortic valve interventions (TAVI) and other catheter-based treatments - as well as coronary… View more
Multimodality Imaging in Cardiac Amyloidosis with Dr Vasvi Singh
Author(s): Vasvi Singh Added: 4 months ago
Navigate the diagnostic complexities of cardiac amyloidosis through expert multimodality imaging techniques with Dr Vasvi Singh.This comprehensive presentation, part of the Cardiomyopathies track, addresses the critical role of advanced imaging in diagnosing cardiac amyloidosis. Dr Singh explores the nuanced differences between SPECT and SPECT-CT imaging capabilities, providing practical insights… View more

Heart Failure

Imaging & Diagnostics